How to Manage Febrile Neutropenia During the COVID Pandemic?
- PMID: 32399999
- PMCID: PMC7418344
- DOI: 10.1634/theoncologist.2020-0285
How to Manage Febrile Neutropenia During the COVID Pandemic?
Abstract
This letter to the editor reflects on the recently published article about management of cancer patients during the COVID‐19 pandemic by Al‐Shamsi et al., specifically as regards the management of febrile neutropenia in the context of the pandemic.
Comment in
-
In Reply.Oncologist. 2020 Aug;25(8):e1252-e1253. doi: 10.1634/theoncologist.2020-0329. Epub 2020 May 27. Oncologist. 2020. PMID: 32378772 Free PMC article.
Comment on
-
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27. Oncologist. 2020. PMID: 32243668 Free PMC article. Review.
References
-
- Kochanek M, Schalk E, von Bergwelt‐Baildon M et al. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 2019;98:1051–1069. - PMC - PubMed
-
- Ahn S, Lee YS. Predictive factors for poor prognosis febrile neutropenia. Curr Opin Oncol 2012;24:376–380. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical